4.1 Article

Functional Impairment in the Diagnosis of Mild Cognitive Impairment

Journal

ALZHEIMER DISEASE & ASSOCIATED DISORDERS
Volume 25, Issue 3, Pages 225-229

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WAD.0b013e318209d517

Keywords

mild cognitive impairment; functional activity; diagnostic criteria; predictive validity; dementia

Funding

  1. Pfizer Global Pharmaceuticals [06-05-039]
  2. Ministry for Health, Welfare and Family Affairs, Republic of Korea [A092077]
  3. Esai Korea
  4. Wyeth Pharmaceuticals
  5. Eli Lilly
  6. H. Lundbeck A/S
  7. Ministry of Health and Welfare, Korea

Ask authors/readers for more resources

The criterion on functional activity in the revised diagnostic criteria for mild cognitive impairment (MCI) seems to be conceptually and operationally problematic. We investigated the predictive validity for dementia of this criterion in 140 patients with MCI who participated in the baseline study of the Korean Longitudinal Study on Health and Aging and completed 18-month follow-up evaluation (mean duration of follow-up, 1.57 +/- 0.24 y). Annual conversion rates to dementia were compared between the patients who fulfilled the criterion on functional activity and those who did not. Annual conversion rates to dementia of the patients who fulfilled the criterion on functional activity was 4.76%, whereas that of the patients with MCI who did not was 33.07%, indicating that the criterion on functional activity was a significant negative predictor of dementia (odds ratio = 0.12). Re-revision of the criterion on functional activity may be warranted to solve its conceptual and operational ambiguities.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available